BeiGene, Ltd. (ONC) — Cash Flow-to-Debt Ratio
BeiGene, Ltd. (ONC) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of $201.94 Million could theoretically repay 0% of its total liabilities ($3.79 Billion) in one year. Explore how much of BeiGene, Ltd.'s assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BeiGene, Ltd. Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for BeiGene, Ltd. across 13 annual periods. Also explore ONC total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for BeiGene, Ltd. (2013–2025)
Year-by-year debt coverage analysis for BeiGene, Ltd.. For market capitalisation and broader financial context, see ONC market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | $1.13 Billion | $3.83 Billion | ▲ +642.3% |
| 2024 | -0.05x | $-140.63 Million | $2.59 Billion | ▲ +89.4% |
| 2023 | -0.51x | $-1.16 Billion | $2.27 Billion | ▲ +31.9% |
| 2022 | -0.75x | $-1.50 Billion | $2.00 Billion | ▼ -38.7% |
| 2021 | -0.54x | $-1.30 Billion | $2.40 Billion | ▲ +27.1% |
| 2020 | -0.74x | $-1.28 Billion | $1.73 Billion | ▲ +37.4% |
| 2019 | -1.18x | $-750.27 Million | $633.93 Million | ▼ -7.2% |
| 2018 | -1.10x | $-547.72 Million | $496.04 Million | ▼ -3236.7% |
| 2017 | 0.04x | $12.75 Million | $362.25 Million | ▲ +102.1% |
| 2016 | -1.69x | $-89.51 Million | $52.91 Million | ▼ -80.2% |
| 2015 | -0.94x | $-39.84 Million | $42.45 Million | ▼ -200.7% |
| 2014 | -0.31x | $-8.69 Million | $27.85 Million | ▼ -473.7% |
| 2013 | 0.08x | $4.07 Million | $48.76 Million | — |